Pro-Bac 4 + IBRk and BVDk with Reveal ATS Cattle Vaccine, 100 dose, 200-ml

Pro-Bac 4+ IBRk & BVDk with Reveal ATS Cattle Vaccine vaccine line was developed specifically for stocker and feeder cattle and offers the most complete protection against five of the most common BRD-causing bacteria:

• Mannheimia haemolytica Type A1 (MhA1)
• Mannheimia haemolytica Type A6 (MhA6)
• Pasteurella multocida (Pm)
• Histophilus somni / Haemophilus somnus (Hs)
• Salmonella typhimurium (St)

Key Features:

• QUALITY BACTERIAL ANTIGENS

  Our antigens are grown in specific conditions to maximize expression of all virulence factors, which optimizes post-injection antigen presentation in order to elicit a stronger immune response to better protect your cattle against the bacterial challenges they may face later on whether that is on the ranch or in the feedlot.

• CONVENIENCE

  Available in both 50-dose and 100-dose bottles, PRO-BAC vaccines come ready-to-use requiring no chute-side mixing and are administered in a BQA-friendly 2.0 mL subcutaneous (SQ) dose in the side of the neck.

• VERSATILITY

  Choose the right antigen combination to plug into your current vaccination protocol to fill the gaps other vaccines aren't covering to set your calves up to perform on the ranch and in the feedlot.

• EFFICACY

  Our unique manufacturing process and proprietary adjuvant system (Reveal ATS™) results in vaccines that provide a high level of protection against the costliest BRD-causing bacteria without the harsh side effects often associated with the vaccination of mid- to high-risk cattle.

Indications

This product has been shown to be effective for the vaccination of healthy cattle three months of age or older against Infectious Bovine rhinotracheitis, Bovine Viral Diarrhea Type 1, Haemophilus Somnus, Mannheimia Haemolutica Type A-1, Mannheimia Haemolutica Type A-6, & Pasteurella Multocida Type A-3. Duration of immunity has not been determined. For more information regarding efficacy and safety data, see product data.aphis.usda.gov.

This product contains inactivated Mannheimia Haemolytica leukotoxin and cell-associated antigens.

Mix well and aseptically inhect 2.0 ml subcutaneously in the side of the neck. Give a second dose 14 days after the first on the opposite side of the neck.

If severe exposure to IBR and/or BVD is anticipated, consideration should be given to re-vaccination with modified-live IBR and/or BVD vaccine.

Cautions:

Do not mix with other products. May cause local swelling. Do not inhect into muscle, may cause carcass trim. Do not vaccinate within 60 days of slaughter. Do not contaminate with dirt or chemicals. Use sterile equipment and adequately clean and disinfect bottle cap prior to each entry. Use entire contents when opened. Store at 2° to 8° C. Do not use if emulsion is broken as indicated by separation at the BOTTOM of bottle. In case of human exposre, contact a physician. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy. This product has not been tested in pregnant animals.

This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious, disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.